Authorised Therapeutic use (Phase IV) Chronic postsurgical pain after open inguinal hernia mesh repair

Preincisional versus postincisional ultrasound-guided transversus abdominis plane (TAP) block comparative effect on chronic postsurgical pain in patients undergoing open inguinal hernia mesh repair

EU CTIS ID: 2024-513582-39-01

What this study is testing

To assess de difference in chronic postsurgical pain incidence between patients who receive the TAP block pre versus post open inguinal hernia mesh repair using the sf-IPQ questionnaire three months after the surgery

  • Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Patients over 18 years old
  • Patients scheduled to undergo open inguinal hernia mesh repair accoding to Lichtenstein technique
  • Patients with symptomatic inguinal hernia clinically confirmed or with image test
  • Ability to give written informed consent
  • Patients with clinical consideration ASA I, II or III

You likely can't join if

  • Recurrent hernias or those requiring a different therapeutic technique
  • Urgent or complicated surgery or hernia
  • Previous chronic inguinal pain
  • Severe neuromuscular disorders
  • Pregnancy or lactation
  • Previous opioid treatment
See the full eligibility criteria
Who can join
  • Patients over 18 years old
  • Patients scheduled to undergo open inguinal hernia mesh repair accoding to Lichtenstein technique
  • Patients with symptomatic inguinal hernia clinically confirmed or with image test
  • Ability to give written informed consent
  • Patients with clinical consideration ASA I, II or III
What rules you out
  • Recurrent hernias or those requiring a different therapeutic technique
  • Urgent or complicated surgery or hernia
  • Previous chronic inguinal pain
  • Severe neuromuscular disorders
  • Pregnancy or lactation
  • Previous opioid treatment
  • Inability to understand the trial's instructions
  • Patients participating in other trials at the same time
  • Allergy to any of the drugs used

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.